Evidence map›Paper›PMID 30745727›Full record

ArticleClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology2019

Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report.

Shinji Takeyari, Satoshi Takakuwa, Kei Miyata, Kenichi Yamamoto, Hirofumi Nakayama, Yasuhisa Ohata, Makoto Fujiwara, Taichi Kitaoka, Takuo Kubota, Noriyuki Namba and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Systematic review of genotype-stratified treatment for monogenic insulin resistance.medRxiv : the preprint server for health sciences · 2023
    Article
  3. A new mutation in theFrontiers in endocrinology · 2023
    Review
  4. Article
  5. The long-term management of congenital generalized lipodystrophy (Berardinelli-Seip syndrome): the clinical manifestations of Japanese siblings for approximately 20 years.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Shinji TakeyariDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Satoshi TakakuwaDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Kei MiyataDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Kenichi YamamotoDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Hirofumi NakayamaDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Yasuhisa OhataDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Makoto FujiwaraDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Taichi KitaokaDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Takuo KubotaDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Noriyuki NambaDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Norio SakaiDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Keiichi OzonoDepartment of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Osaka University · JPJapan Community Healthcare Organization · JPOsaka Health Science University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital generalized lipodystrophy type 4 (CGL4) is a rare disease caused by mutations in the gene polymerase I and transcript release factor (

Indexed as

congenital generalized lipodystrophyleptinmetreleptinPTRF

Identifiers

PMID30745727
PMCPMC6356095
OpenAlexW2911538666

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.